Cell Division Quality Control ‘Stopwatch’ Uncovered

“This work shows that cells carefully monitor the time taken to execute mitosis and use that as a filter to eliminate potentially problematic cells,” said Desai, a faculty member in the Department of Cell and Developmental Biology. “If a cell takes longer than normal to complete mitosis, then daughter cells will know that their mother struggled to execute mitosis and they’ll stop dividing as a safety measure.”

The researchers discovered that the stopwatch is made up of a biochemical pathway that continually surveils the amount of time spent in mitosis. The pathway features a “memory” function that sums up mitosis delays from one generation to the next. Underlying the pathway is a complex of three proteins, including p53, encoded by the most commonly mutated gene in human cancers. Through a series of experiments, the researchers followed the pathway from parent to daughter and granddaughter cells over a 48-hour period. They found that the pathway works as a quality control mechanism that “remembers” mitotic time. Even cell divisions that are sequentially delayed by as little as 20 minutes are labeled as risky, they found.

The researchers believe the crucial 30 minutes of mitotic time could be evolution’s solution to quickly getting through a vital but potentially dangerous part of life when cells are vulnerable. Cancers, in Oegema’s view, are like an alien in our bodies that we are constantly fighting off using surveillance mechanisms like the stopwatch. Importantly, the researchers demonstrated that the stopwatch mechanism is switched “off” by many types of cancers, effectively allowing them to tolerate aberrant genomes that undergo longer and problematic mitoses.

“Our research suggests that measuring mitosis time is a mechanism that was developed as a way to protect us,” said Oegema, also a Cell and Developmental Biology Department professor. “Essentially, it’s another tumor-suppression function tied to p53’s job to protect against problematic cells.”

Looking ahead, the researchers noted in their Science study that their discovery could be used in future treatment strategies for cancer patients.

“Stopwatch status may influence the efficacy of therapeutic agents currently in use or being developed to target mitotic processes,” they note in the report, “and could serve as a potential biomarker for their use in cancer treatment.”

The coauthors of the paper are: Franz Meitinger, Hazrat Belal, Robert Davis, Mallory Martinez, Andrew Shiau, Karen Oegema and Arshad Desai.

The research was supported by: National Institutes of Health (grants GM074207 and GM074215); German Research Foundation (grant ME 4713/1-1); Ludwig Institute for Cancer Research; Okinawa Institute of Science and Technology; and Japan Society for the Promotion of Science (KAKENHI grant 23K05773).